• to reduce the potential risk of major cardiovascular (coronary heart and blood vessel) troubles in Grown ups with variety two diabetes and cardiovascular diseaseNovo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd,[three] with output services in 9 countries and affiliate marketers or offices in five.Only